TrialMolecular oncology2016

Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer.

Kjersti Tjensvoll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.